Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

A New AdvancedMRIBiomarker for Remyelinated Lesions in Multiple Sclerosis | Synapse

June 17, 2022Open Access

View Full Paper

A New AdvancedMRIBiomarker for Remyelinated Lesions in Multiple Sclerosis

Key Points

Key points are not available for this paper at this time.

Abstract

These results provide the first evidence that it is possible to distinguish chronic MS lesions in a clinical setting, hereby supporting with new biomarkers to develop and assess remyelinating treatments. ANN NEUROL 2022;92:486-502.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Rahmanzadeh et al. (Fri,) studied this question.

synapsesocial.com/papers/69d9d986a1d151c65f6853f1 https://doi.org/https://doi.org/10.1002/ana.26441

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging2021 · 112 citations
2FSL2011 · 11,922 citations
3Multiple Sclerosis Pathology2018 · 889 citations
4Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging2016 · 474 citations
5An updated histological classification system for multiple sclerosis lesions2016 · 701 citations